Mangano v. PeriCor

Summary

Hearing on motion for partial summary judgment and partial judgment on the pleadings.

Mangano, plaintiff, co-founded PeriCor Therapeutics, defendant, in 2004 and owns 45% of the biotech company, alleging breach of a voting trust agreement.

PeriCor Therapeutics, Inc. is a private, clinical-stage specialty biopharmaceutical company focused on developing novel therapies to prevent the morbidity and mortality caused by myocardial injury